Cue Health and healthcare technology company Cardinal Health announced expanded distribution of Cue's COVID-19 tests, which are for use in both clinical and over-the-counter settings.
Cardinal Health serves approximately 90% of U.S. hospitals and more than 60,000 pharmacies, and its distribution network includes hospitals, pharmacies, and nonclinical consumer markets. This network will help accelerate the reach of Cue's nucleic acid amplification test into both traditional and nontraditional healthcare settings, Cue said in a press release.
